Risk for renal injury in diabetic hypertensive patients

References

• Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial: risk factor changes and mortality results. JAMA 1982: 248(12): 1465–77
   PubMed Web of Science ®Google Scholar
• Parving HH. The impact of hypertension and antihypertensive treatment on the course and prognosis of diabetic nephropathy. J Hypertens 1990: 8(Suppl 7): S187–91
   Google Scholar
• Klein BE, Klein R, Moss SE. Blood pressure in a population of diabetic persons diagnosed after 30 years of age. Am J Public Health 1984: 74(4): 336–9
   PubMed Web of Science ®Google Scholar
• The Working Group on Hypertension in Diabetes. Statement on hypertension in diabetes mellitus: final report. Arch Intern Med 1987: 147(5): 830–42
   PubMedGoogle Scholar
• Fuller JH. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985: 7(6 Pt 2): 113–7
   PubMedGoogle Scholar
• United Kingdom Prospective Diabetes Study. III. Prevalence of hypertension and hypotensive therapy in patients with newly diagnosed diabetes: a multicenter study. Hypertension 1985: 7(6 Pt 2): 118–13
   PubMedGoogle Scholar
• Swislocki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989: 2(6 Pt 1): 419–23
   PubMed Web of Science ®Google Scholar
• Shen DC, Shieh SM, Fuh MM, et al. Resistance to insulin-stimulated-glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988: 66(3): 580–3
   PubMed Web of Science ®Google Scholar
• Fuh MM, Shieh SM, Wu DA, et al. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 1987: 147(6): 1035–8
   PubMedGoogle Scholar
• Singer P, Godicke W, Voigt S, et al. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension 1985: 7(2): 182–6
   PubMed Web of Science ®Google Scholar
• Lucas CP, Estigarribia JA, Darga LL, et al. Insulin and blood pressure in obesity. Hypertension 1985: 7(5): 702–6
   PubMed Web of Science ®Google Scholar
• Manicardi Camellini L, Bellodi G, et al. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 1986: 62(6): 1302–4
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987: 317(6): 350–7
   PubMed Web of Science ®Google Scholar
• Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985: 75(3): 809–17
   PubMed Web of Science ®Google Scholar
• Reaven GM, Hoffman BB. Hypertension as a disease of carbohydrate and lipoprotein metabolism. Am J Med 1989: 87(6A): 2–6S
   PubMed Web of Science ®Google Scholar
• Sowers JR, Levy J, Zemel MB. Hypertension and diabetes. Med Clin North Am 1988: 72(6): 1399–414
   PubMed Web of Science ®Google Scholar
• Berglund G, Larsson B, Andersson O, et al. Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med Scand 1976: 200(3): 163–9
   PubMedGoogle Scholar
• Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988: 37(12): 1595–607
   PubMed Web of Science ®Google Scholar
• Christlieb AR, Krolewski AS, Warram JH, et al. Is insulin the link between hypertension and obesity? Hypertension 1985: 7(6 Pt 2): 1154–7
   Google Scholar
• Sowers JR. Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism. J Am Soc Nephrol 1990: 1(3): S39–47
   PubMed Web of Science ®Google Scholar
• Fuller JH, Shipley MJ, Rose G, et al. Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1980: 1(8183): 1373–6
   PubMed Web of Science ®Google Scholar
• Kannel WB. A general cardiovascular risk profile: the Framingham Study. Am J Cardiol 1976: 38(1): 46–51
   PubMed Web of Science ®Google Scholar
• Thygesen K, Strate M, Hansen L, et al. Survival of diabetic hypertensive patients. Hypertension 1985: 7(6 Pt 2): 1114–7
   Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. JAMA 1982: 248(16): 2004–11
   Google Scholar
• Whelton PK. Systemic hypertension, diuretic drugs, arrhythmias and death. Am J Cardiol 1985: 55(1): 221–2
   PubMed Web of Science ®Google Scholar
• Weinberger MH. Antihypertensive therapy and lipids: evidence, mechanisms, and implications. Arch Intern Med 1985: 145(6): 1102–5
   PubMedGoogle Scholar
• Hollifield JW, Slaton PE. Thiazide diuretics, hypokalemia and cardiac arrhythmias. Acta Med Scand 1981: 647(Suppl): 67–73
   Google Scholar
• Stewart DE, Ikram H, Espiner EA, et al. Arrhythmogenic potential of diuretic induced hypokalemia in patients with mild hypertension and ischaemic heart disease. Br Heart J 1985: 54(3): 290–7
   PubMedGoogle Scholar
• Bakris GL, Frohlich ED. The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol 1989: 14(7): 1595–608
   PubMed Web of Science ®Google Scholar
• Houston MC. Treatment of hypertension in diabetes mellitus. Am Heart J 1989: 118(4): 819–29
   PubMed Web of Science ®Google Scholar
• Bakris GL. The effects of calcium antagonists on renal hemodynamics, urinary protein excretion and glomerular morphology in diabetic states. J Am Soc Nephrol 1991: 2(2 Suppl): 21–9
   Google Scholar
• Brownlee M, Vlassara H, Kooney A, et al. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. Science 1986: 232(4758): 1629–32
   PubMed Web of Science ®Google Scholar
• Sowers JR, Khoury S, Standley P, et al. Mechanisms of hypertension in diabetes. Am J Hypertens 1991: 4(2 Pt 1): 177–82
   PubMed Web of Science ®Google Scholar
• Alexander WD, Oake RJ. The effect of insulin on vascular reactivity to norepinephrine. Diabetes 1977: 26(7): 611–4
   PubMed Web of Science ®Google Scholar
• Jansen RW, Penterman BJ, van Lier HJ, et al. Blood pressure reduction after oral glucose loading and its relation to age, blood pressure and insulin. Am J Cardiol 1987: 60(13): 1087–91
   PubMed Web of Science ®Google Scholar
• Hall JE, Brands MW, Kivlighn SD, et al. Chronic hyperinsulinemia and blood pressure: interaction with catecholamines? Hypertension 1990: 15(5): 519–27
   PubMed Web of Science ®Google Scholar
• Mathias CJ, da Costa DF, Fosbraey P, et al. Hypotensive and sedative effects of insulin in autonomic failure. BMJ (Clin Res) 1987: 295(6591): 161–3
   PubMedGoogle Scholar
• Hall JE, Coleman TG, Mizelle HL. Does chronic hyperinsulinemia cause hypertension? Am J Hypertens 1989: 2(3 Pt 1): 171–3
   PubMed Web of Science ®Google Scholar
• Weidmann P, Beretta-Piccoli C, Trost BN. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 1985: 7(6 Pt 2): 1133–42
   Google Scholar
• Olshan AR, O'Connor DT, Cohen IM, et al. Hypertension in adult onset diabetes mellitus: abnormal renal hemodynamics and endogenous vasoregulatory factors. Am J Kidney Dis 1982: 2(2): 271–80
   PubMed Web of Science ®Google Scholar
• Zemel MB, Sowers JR, Shehin S, et al. Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism 1990: 39(7): 704–8
   PubMed Web of Science ®Google Scholar
• Levy J, Zemel MB, Sowers J. Mineral homeostasis in an animal model for obesity. J Bone Min Res 1988: 3(Suppl 1): 505–10
   Google Scholar
• Shehin SE, Sowers JR, Zemel MB. Impaired vascular smooth muscle 45Ca efflux and hypertension in Zucker obese rats. J Vase Med Biol 1989: 1(4): 278–82
   Google Scholar
• Zemel MB, Reddy S, Shehin SE, et al. Vascular reactivity in Zucker obese rats: role of insulin resistance. J Vase Med Biol 1990: 2(1): 81–5
   Google Scholar
• Shaefer W, Prieben J, Mannhold R, et al. CA2+-Mg2+-ATPase activity of human red blood cells in healthy and diabetic volunteers. Klin Wochenschr 1987: 65(10): 17–21
   PubMedGoogle Scholar
• Reddy S, Shehin SS, Sowers JR, et al. Aortic 45Ca flux and blood pressure regulation in streptozotocin-induced diabetic rats. J Vase Med Biol 1990: 2(1): 47–51
   Google Scholar
• Colwell JA, Lopes-Virella M, Halushka PV. Pathogenesis of atherosclerosis in diabetes mellitus. Diabetes Care 1981: 4(1): 121–33
   PubMed Web of Science ®Google Scholar
• Christlieb AR, Kaldany A, D'Elia JA. Plasma renin activity and hypertension in diabetes mellitus. Diabetes 1976: 25(10): 969–74
   PubMed Web of Science ®Google Scholar
• Punzi HA, Kaplan N. Therapy for hypertension in the diabetic. I. Nonpharmacologic intervention. Cardiovasc Rev Rep 1987 Oct: 61–3
   Google Scholar
• Punzi HA, Kaplan N. Therapy for hypertension in the diabetic patient. II. Pharmacologic intervention. Cardiovasc Rev Rep 1987 Nov: 37–41
   Google Scholar
• Pederson O, Beck-Nielsen SH, Heding L. Increased insulin receptors after exercise in a patient with insulin-dependent diabetes mellitus. N Engl J Med 1980: 302(16): 886–92
   PubMed Web of Science ®Google Scholar
• Lipson LG. Special problems in treatment of hypertension in the patient with diabetes mellitus. Arch Intern Med 1984: 144(9): 1829–31
   PubMedGoogle Scholar
• Zeller K, Whittaker E, Sullivan L, et al. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus. N Engl J Med 1991: 324(2): 78–84
   PubMed Web of Science ®Google Scholar
• Folkow B. Structural myogenic, humoral and nervous factors controlling peripheral resistance. In: Harrington M, ed. Hypotensive drugs. Elmsford, NY: Pergamon Press, 1956: 163–74
   Google Scholar
• Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy of resistance vessels? J Hypertens 1986: 4(5): 515–24
   PubMed Web of Science ®Google Scholar
• Anderson S, Rennke HG, Brenner BM. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 1986: 77(6): 1993–2000
   PubMed Web of Science ®Google Scholar
• Anderson S, Meyer TW, Rennke HG, et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985: 76(2): 612–9
   PubMed Web of Science ®Google Scholar
• Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986: 80(3): 435–42
   PubMed Web of Science ®Google Scholar
• Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure: less of one, more the other? Am J Hypertens 1988: 1(4Pt 1): 335–47
   PubMedGoogle Scholar
• Lund-Johansen P. The hemodynamics of essential hypertension. In: Robertson JI, ed. Handbook of hypertension: clinical aspects of essential hypertension. New York: Elsevier Science Publishing, 1983: 151–73
   Google Scholar
• Messerli FH, Garavaglia GE. Cardiodynamics of hypertension: a guide to selection of therapy. J Clin Hypertens 1986: 2(3 Suppl): 100–8S
   Google Scholar
• Weir MR, Sowers JR. Physiologic and hemodynamic considerations in blood pressure control while maintaining organ perfusion. Am J Cardiol 1988: 61(16): 60–6H
   Web of Science ®Google Scholar
• Dustan HP, Curds JJ, Luke RG, et al. Systemic hypertension and the kidney in black patients. Am J Cardiol 1987: 60(17): 73–71
   Google Scholar
• Raij L, Keane WF. Glomerular mesangium: its function and relationship to angiotensin II. Am J Med 1985: 79(3C): 24–30
   PubMed Web of Science ®Google Scholar
• Bakris GL, Akerstron V, Re R. Insulin, angiotensin II and endothelin effects on human mesangial cells. (Abstract) Hypertension 1990: 16(3): 326A
   Web of Science ®Google Scholar
• Parving HH, Mogensen CE, Jensen HA, et al. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1974: 1(868): 1190–2
   PubMedGoogle Scholar
• Pedersen EB, Mogensen CE. Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest 1976: 36(3): 231–7
   PubMed Web of Science ®Google Scholar
• Pedersen EB. Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension. Acta Med Scand Suppl 1980: 636: 1–66
   PubMedGoogle Scholar
• Epstein M, Hayashi K, Forster H, et al. Impaired myogenic afferent arteriolar vasoconstriction in genetically diabetic rats. (Abstract) J Am Soc Nephrol 1990: 1(4): 627A
   Google Scholar
• Laragh JH. Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment. Am J Med 1989: 87(6B): 2–14S
   PubMedGoogle Scholar